Counterweight Publications 2004 - 2025 (Current)

2025
Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial
Nature Medicine
https://www.nature.com/articles/s41591-024-03384-x

2024
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study
The Lancet Diabetes & Endocrinology
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00385-6/fulltext

A preoperative package of care for osteoarthritis, consisting of weight loss, orthotics, rehabilitation, and topical and oral analgesia (OPPORTUNITY): a two-centre, open-label, randomised controlled feasibility trial.
Lancet Rheumatology
https://doi.org/10.1016/ S2665-9913(23)00337-5

Baseline Characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT).
NIHR Open Research
https://doi.org/10.3310/nihropenres.13522.1

Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial.
The Lancet Regional Health- Europe
https://doi.org/10.1016/j.lanepe.2024.100853

The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT).
Diabetologia.
https://doi.org/10.1007/s00125-023-06019-x

Translation of a Diabetes Remission Service into Australian Primary Care: Findings from the Evaluation of DiRECT-Australia.
Journal Diabetes Research
https://doi.org/10.1155/2024/2350551

A qualitative study of the perceptions and experiences of participants and healthcare professionals in the DiRECT-Australia type 2 diabetes remission service.
Diabetic Medicine.
https://doi.org/10.1111/dme

2023
The remote diet intervention to reduce Long COVID symptoms trial (ReDIRECT): protocol for a randomised controlled trial to determine the effectiveness and cost-effectiveness of a remotely delivered supported weight management programme for people with Long COVID and excess weight, with personalised improvement goals
NIHR Open Research
https://openresearch.nihr.ac.uk/articles/2-57/v2A

Total Diet Replacement Weight Management Program for Difficult-to-Treat Asthma Associated With Obesity: A Randomized Controlled Feasibility
Trial Chest Journal
https://journal.chestnet.org/article/S0012-3692%2823%2900117-4/fulltext

Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT)
Diabetic Medicine
https://pubmed.ncbi.nlm.nih.gov/36398460/

2022
Dietary weight-management for type 2 diabetes remissions in South Asians: the SouTh AsiaN Diabetes remission feasiBilitY and randomised trial (STANDby)
Lancet Regional Health Southeast Asia
http://dx.doi.org/10.2139/ssrn.4162716

Real-World Data of a Group-Based Formula Low Energy Diet Programme in Achieving Type 2 Diabetes Remission and Weight Loss in an Ethnically Diverse Population in the UK: A Service Evaluation
Nutrients
http://dx.doi.org/10.3390/nu14153146

2021
Delivering the Diabetes Remission Clinical Trial (DiRECT) in primary care: Experiences of healthcare professionals
Diabetic Medicine
https://doi.org/10.1111/dme.14752

Participant experiences in the Diabetes Remission Clinical Trial (DiRECT)
Diabetic Medicine
https://doi.org/10.1111/dme.14689

Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)
Diabetologia
https://doi.org/10.1007/s00125-021-05471-x

Brief formula low-energy-diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT)
Journal of Human Nutrition and Dietetics
https://doi.org/10.1111/jhn.12839

2020
The role of appetite-related hormones, adaptive thermogenesis, perceived hunger and stress in long-term weight-loss maintenance: a mixed-methods study European
Journal of Clinical Nutrition
https://doi.org/10.1038/s41430-020-0568-9

Osteoarthritis Preoperative Package for care of Orthotics, Rehabilitation, Topical and oral agent Usage and Nutrition to Improve ouTcomes at a Year (OPPORTUNITY); a feasibility study protocol for a randomised controlled trial
Trials
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3709-5‘

I have been all in, I have been all out and I have been everything in-between’: A 2-year longitudinal qualitative study of weight loss maintenance
Journal of Human Nutrition and Dietetics
https://doi.org/10.1111/jhn.12826

Weight loss-induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT)
Diabetes, Obesity and Metabolism
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14274

2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial
The Lancet Diabetes & Endocrinology
https://doi.org/10.1016/S2213-8587(20)30303-X

Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)
Diabetic Medicine
https://doi.org/10.1111/dme.14395

Time course of normalization of functional β-cell capacity in the Diabetes Remission Clinical Trial after weight loss in type 2 diabetes
Diabetes Care
https://doi.org/10.2337/dc19-0371

Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss
Cell Metabolism
https://doi.org/10.1016/j.cmet.2019.11.018

Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme
Diabetologia
https://doi.org/10.1007/s00125-020-05224-2

2019
The DiRECT principles: giving Type 2 diabetes remission programmes the best chance of success
Diabetic Medicine
https://doi.org/10.1111/dme.14126

Low-calorie diets in the management of type 2 diabetes mellitus
Nature Reviews/Endocrinology
https://doi.org/10.1038/s41574-019-0186-6

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
The Lancet Diabetes and Endocrinology
https://doi.org/10.1016/S2213-8587(19)30068-3

2018
Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes
Lancet Diabetes and Endocrinology
https://doi.org/10.1016/S2213-8587(18)30346-2

Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for b Cell Recovery
Cell Metabolism
https://doi.org/10.1016/j.cmet.2018.07.003

Filling the intervention gap: service evaluation of an intensive nonsurgical weight management programme for severe and complex obesity
Journal of Human Nutrition and Dietetics
https://doi.org/10.1111/jhn.12611

2017
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open- label, cluster-randomised trial
The Lancet
https://doi.org/10.1016/S0140-6736(17)33102-1

Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort
Diabetologia
https://doi.org/10.1007/s00125-017-4503-0

Beating type 2 diabetes into remission
BMJ
https://doi.org/10.1136/bmj.j4030

2016
The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial
BMC Family Practice
https://doi.org/10.1186/s12875-016-0406-2

2013
Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity
British Journal of General Practice
https://doi.org/10.3399/bjgp13X663073

A community pharmacy weight management programme: an evaluation of effectiveness
BMC Public Health
https://doi.org10.1186/1471-2458-13-282

2012
The implementation of the Counterweight Programme in Scotland, UK
Family Practice
https://doi.org/10.1093/fampra/cmr074

2008
A patient-centred approach to estimate total annual healthcare cost by body mass index in the UK Counterweight programmeInternational
Journal of Obesity
https://doi.org/10.1038/ijo.2012.186

The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change
Obesity Research & Clinical Practice
https://doi.org/10.1016/j.orcp.2008.01.002

Tricks and tools for the primary care provider: the counterweight programme: a continuous improvement methodology model of weight management in UK primary care
International Journal of Obesity
https://www.semanticscholar.org/paper/Tricks-and-tools-for-the-primary-care-provider-The-McQuigg-Broom/c84aed0f3729e579d70e4cfa7167be56b11d3f1e

Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care
Journal of health services research & policy
http://www.jstor.org/stable/26751614

Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement
British Journal of General Practice
https://bjgp.org/content/bjgp/58/553/548.full.pdf

2005
Empowering primary care to tackle the obesity epidemic: the Counterweight Programme
European Journal of Clinical Nutrition
https://doi.org/10.1038/sj.ejcn.1602180

Engaging patients, clinicians and health funders in weight management: the Counterweight Programme
Family Practice
https://doi.org/10.1093/fampra/cmn081

2004
Current approaches to obesity management in UK Primary Care: the Counterweight Programme
Journal of Human Nutrition and Dietetics
https://doi.org/10.1111/j.1365-277X.2004.00528.x

A new evidence based model for weight management in primary care: the Counterweight Programme
Journal of Human Nutrition and Dietetics
https://doi.org/10.1111/j.1365-277X.2004.00517.x